JPS6040859B2 - 抗血栓性人工医療材料 - Google Patents
抗血栓性人工医療材料Info
- Publication number
- JPS6040859B2 JPS6040859B2 JP52090673A JP9067377A JPS6040859B2 JP S6040859 B2 JPS6040859 B2 JP S6040859B2 JP 52090673 A JP52090673 A JP 52090673A JP 9067377 A JP9067377 A JP 9067377A JP S6040859 B2 JPS6040859 B2 JP S6040859B2
- Authority
- JP
- Japan
- Prior art keywords
- heparin
- solution
- antithrombin
- immobilized
- artificial medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000012567 medical material Substances 0.000 title claims description 15
- 239000003146 anticoagulant agent Substances 0.000 title claims description 12
- 230000002785 anti-thrombosis Effects 0.000 title claims description 11
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 36
- 229960002897 heparin Drugs 0.000 claims description 36
- 229920000669 heparin Polymers 0.000 claims description 36
- 229920000936 Agarose Polymers 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 6
- 229920003176 water-insoluble polymer Polymers 0.000 claims description 6
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 claims description 5
- 230000003100 immobilizing effect Effects 0.000 claims description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 4
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 claims description 3
- 102000004411 Antithrombin III Human genes 0.000 claims 3
- 108090000935 Antithrombin III Proteins 0.000 claims 3
- 229960005348 antithrombin iii Drugs 0.000 claims 3
- 239000000243 solution Substances 0.000 description 38
- 239000004019 antithrombin Substances 0.000 description 35
- 238000000034 method Methods 0.000 description 20
- 239000000463 material Substances 0.000 description 14
- 108090000190 Thrombin Proteins 0.000 description 13
- 229960004072 thrombin Drugs 0.000 description 13
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 230000002429 anti-coagulating effect Effects 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000023555 blood coagulation Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 108010049003 Fibrinogen Proteins 0.000 description 3
- 102000008946 Fibrinogen Human genes 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 229940012952 fibrinogen Drugs 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 239000010414 supernatant solution Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010053567 Coagulopathies Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 240000007472 Leucaena leucocephala Species 0.000 description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000035602 clotting Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241001062872 Cleyera japonica Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 244000309456 Decussocarpus nagi Species 0.000 description 1
- 235000008375 Decussocarpus nagi Nutrition 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 244000144992 flock Species 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/815—Carrier is a synthetic polymer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP52090673A JPS6040859B2 (ja) | 1977-07-27 | 1977-07-27 | 抗血栓性人工医療材料 |
| DE19782832536 DE2832536A1 (de) | 1977-07-27 | 1978-07-25 | Kuenstliches medizinisches material mit gerinnungshemmender wirkung |
| US05/927,941 US4213962A (en) | 1977-07-27 | 1978-07-25 | Artificial medical material with anticoagulative activity |
| GB787831055A GB2001528B (en) | 1977-07-27 | 1978-07-25 | Artificial medical material with anticoagulative activity |
| SE7808161A SE447628B (sv) | 1977-07-27 | 1978-07-26 | Medicinskt material med antikoagulerande aktivitet vilket utgores av berarmaterial varpa heparin och antitrombin iii er samimmobiliserade |
| CA308,217A CA1116087A (en) | 1977-07-27 | 1978-07-26 | Artificial medical material with anticoagulative activity |
| FR7822277A FR2398488A1 (fr) | 1977-07-27 | 1978-07-27 | Matiere artificielle a usage medical douee d'activite anticoagulante |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP52090673A JPS6040859B2 (ja) | 1977-07-27 | 1977-07-27 | 抗血栓性人工医療材料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5424478A JPS5424478A (en) | 1979-02-23 |
| JPS6040859B2 true JPS6040859B2 (ja) | 1985-09-12 |
Family
ID=14005048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52090673A Expired JPS6040859B2 (ja) | 1977-07-27 | 1977-07-27 | 抗血栓性人工医療材料 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4213962A (enExample) |
| JP (1) | JPS6040859B2 (enExample) |
| CA (1) | CA1116087A (enExample) |
| DE (1) | DE2832536A1 (enExample) |
| FR (1) | FR2398488A1 (enExample) |
| GB (1) | GB2001528B (enExample) |
| SE (1) | SE447628B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS597693B2 (ja) * | 1978-01-07 | 1984-02-20 | 株式会社ミドリ十字 | 抗トロンビン製剤及びその製法 |
| FR2461719A2 (fr) * | 1979-07-20 | 1981-02-06 | Choay Sa | Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir |
| USRE35770E (en) * | 1978-11-06 | 1998-04-14 | Choay, S.A. | Oligosaccharides having anti-Xa activity and pharmaceutical compositions containing them |
| AT359646B (de) * | 1979-04-19 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen |
| FR2472390A1 (fr) * | 1979-05-04 | 1981-07-03 | Merieux Inst | Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus |
| IL61201A (en) * | 1979-10-05 | 1984-09-30 | Choay Sa | Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them |
| US4826827A (en) * | 1979-10-05 | 1989-05-02 | Choay S.A. | Short chained oligosaccharides having biological properties, a process for making the same and the use thereof as drugs |
| ATE12779T1 (de) * | 1980-09-30 | 1985-05-15 | Bayer Ag | Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen. |
| DE98814T1 (de) | 1982-06-10 | 1984-06-20 | Kabivitrum Ab, 11287 Stockholm | Antithrombin-heparin komplex. |
| DE3329733A1 (de) * | 1983-08-17 | 1985-03-07 | Johannes Dr.med. 6500 Mainz Reinmüller | Kunststoff-implantat |
| US4689323A (en) * | 1983-09-26 | 1987-08-25 | Miles Laboratories, Inc. | Covalently bound heparin--antithrombin-III complex |
| US4859581A (en) * | 1986-03-10 | 1989-08-22 | Board Of Regents, The University Of Texas System | Endoglycosidase assay |
| US5262451A (en) * | 1988-06-08 | 1993-11-16 | Cardiopulmonics, Inc. | Multifunctional thrombo-resistant coatings and methods of manufacture |
| US5342693A (en) * | 1988-06-08 | 1994-08-30 | Cardiopulmonics, Inc. | Multifunctional thrombo-resistant coating and methods of manufacture |
| US5182317A (en) * | 1988-06-08 | 1993-01-26 | Cardiopulmonics, Inc. | Multifunctional thrombo-resistant coatings and methods of manufacture |
| US7045585B2 (en) * | 1995-11-30 | 2006-05-16 | Hamilton Civic Hospital Research Development Inc. | Methods of coating a device using anti-thrombin heparin |
| US6491965B1 (en) * | 1995-11-30 | 2002-12-10 | Hamilton Civic Hospitals Research Development, Inc. | Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates |
| US6562781B1 (en) * | 1995-11-30 | 2003-05-13 | Hamilton Civic Hospitals Research Development Inc. | Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates |
| US6660301B1 (en) | 1998-03-06 | 2003-12-09 | Biosphere Medical, Inc. | Injectable microspheres for dermal augmentation and tissue bulking |
| AU2001249221A1 (en) | 2000-03-20 | 2001-10-03 | Biosphere Medical, Inc. | Injectable and swellable microspheres for tissue bulking |
| DE102021112467B4 (de) | 2021-05-12 | 2023-03-02 | Technische Universität Hamburg | Synthetisches Thrombusmodell zum Erlernen der operativen Entfernung eines Blutgerinnsels im Rahmen einer Behandlungsnachstellung |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2148011C3 (de) * | 1970-10-05 | 1978-11-09 | Aminkemi Ab | Verfahren zum Herstellen nichtthrombogener Kunststoffoberflächen |
| JPS5515222B2 (enExample) * | 1972-08-18 | 1980-04-22 | ||
| FR2294445A1 (fr) * | 1974-12-09 | 1976-07-09 | Rimbaud Marie | Tube a prelevement pour dosage de la glycemie |
| JPS5236779A (en) * | 1975-09-18 | 1977-03-22 | Showa Electric Wire & Cable Co Ltd | Electromagnetic shielding cable |
| US4048064A (en) * | 1976-04-23 | 1977-09-13 | Clark Iii William T | Biocompatible hemoperfusion system |
| US4073723A (en) * | 1976-11-15 | 1978-02-14 | Swank Roy L | Anti-coagulating and filtering blood |
-
1977
- 1977-07-27 JP JP52090673A patent/JPS6040859B2/ja not_active Expired
-
1978
- 1978-07-25 DE DE19782832536 patent/DE2832536A1/de active Granted
- 1978-07-25 GB GB787831055A patent/GB2001528B/en not_active Expired
- 1978-07-25 US US05/927,941 patent/US4213962A/en not_active Expired - Lifetime
- 1978-07-26 SE SE7808161A patent/SE447628B/sv not_active IP Right Cessation
- 1978-07-26 CA CA308,217A patent/CA1116087A/en not_active Expired
- 1978-07-27 FR FR7822277A patent/FR2398488A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| GB2001528A (en) | 1979-02-07 |
| FR2398488A1 (fr) | 1979-02-23 |
| SE447628B (sv) | 1986-12-01 |
| FR2398488B1 (enExample) | 1983-02-18 |
| GB2001528B (en) | 1982-01-06 |
| JPS5424478A (en) | 1979-02-23 |
| US4213962A (en) | 1980-07-22 |
| CA1116087A (en) | 1982-01-12 |
| SE7808161L (sv) | 1979-01-28 |
| DE2832536C2 (enExample) | 1988-04-21 |
| DE2832536A1 (de) | 1979-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6040859B2 (ja) | 抗血栓性人工医療材料 | |
| CA1199275A (en) | Method of achieving hemostasis | |
| US4800016A (en) | Extracorporeal blood de-heparinization system | |
| KR20010079758A (ko) | 비혈전 형성성 표면 코팅제로서 헤파린을 포함하는 조성물 | |
| US4452785A (en) | Method for the therapeutic occlusion | |
| DE60207053T2 (de) | Rekombinante gelatineartige proteine zur verwendung als plasmaexpander | |
| NL8105656A (nl) | Werkwijze ter bereiding van een conjugaat van heparine en een in water oplosbaar humaan eiwit; werkwijze ter verbetering van de bloedcompatibiliteit van een materiaaloppervlak door bekleding met het conjugaat van heparine en het in water oplosbare humane eiwit, alsmede voorwerp, voorzien van een de bloedcompatibiliteit bevorderende bekleding, gevormd uit het conjugaat van heparine en het in water oplosbare humane eiwit. | |
| US3864478A (en) | Storage-stable hemoglobin solutions and method for their preparation | |
| JPS59133276A (ja) | 結合コラ−ゲン繊維シ−トの製造方法 | |
| CN113769150B (zh) | 一种具有快速凝血作用的复合材料及其制备方法 | |
| US3945889A (en) | Preparation of human placental hyaluronidase | |
| CS249311B1 (en) | Proteolytic wound dressing | |
| CN1557538A (zh) | 高分子树脂型胆红素吸附剂的制备方法 | |
| CA1187074A (en) | Antithrombin-heparin complex and method for its production | |
| JPH06510035A (ja) | 細胞を収容する生物学的適合性カプセルを製造する方法 | |
| Su et al. | A superior material with antithrombotic properties serves as a secure adsorbent for the elimination of bilirubin in vitro and in pig models | |
| JPS647788B2 (enExample) | ||
| JP2003096104A (ja) | 低分子ヘパリンまたはその塩の製造方法 | |
| RU2121503C1 (ru) | Способ очистки коллазы | |
| JPH05500809A (ja) | 新規タンパク質及びその製造 | |
| JPH1024058A (ja) | ポリマー組成物、浸出可能な吸収抗体含有のコンタクトレンズ及びその調整方法 | |
| KR102647642B1 (ko) | 혈액 응고 활성을 갖는 펩타이드와 이의 용도 | |
| JPS6040862B2 (ja) | 抗血栓性材料 | |
| SU1586740A1 (ru) | Способ получени сорбента дл аффинной хроматографии | |
| JPS6011922B2 (ja) | 高活性ヘパリンの製造法 |